Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial

Bader, Peter; Kreyenberg, Hermann; von Stackelberg, Arend; Eckert, Cornelia; Salzmann-Manrique, Emilia; Meisel, Roland; Poetschger, Ulrike; Stachel, Daniel; Schrappe, Martin; Alten, Julia; Schrauder, Andre; Schulz, Ansgar; Lang, Peter; Mueller, Ingo; Albert, Michael H.; Willasch, Andre M.; Klingebiel, Thomas E.; Peters, Christina

Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial

Author:

Bader, Peter; Kreyenberg, Hermann; von Stackelberg, Arend; Eckert, Cornelia; Salzmann-Manrique, Emilia; Meisel, Roland; Poetschger, Ulrike; Stachel, Daniel; Schrappe, Martin; Alten, Julia; Schrauder, Andre; Schulz, Ansgar; Lang, Peter; Mueller, Ingo; Albert, Michael H.; Willasch, Andre M.; Klingebiel, Thomas E.; Peters, Christina

Tübinger Autor(en):

Lang, Peter

Published in:

Journal of Clinical Oncology (2015), Bd. 33, H. 11, S. 1275-1284

Verlagsangabe:

Amer Soc Clinical Oncology

Language:

English

Full text:

http://dx.doi.org/10.1200/JCO.2014.58.4631

ISSN:

0732-183X